Proliferative Vitreoretinopathy: Pathobiology, Surgical Management, and Adjunctive Treatment

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 1995 Oct 1

PMID 7488586

Citations 63

Authors

D G Charteris

Affiliations

Soon will be listed here.

Citing Articles

Assessment of the transscleral removal technique for subretinal proliferative tissues during vitrectomy for rhegmatogenous retinal detachment.

Ishibashi T, Inoue R, Nakashima H, Emi K Jpn J Ophthalmol. 2025; 69(1):66-73.

PMID: 39847184 DOI: 10.1007/s10384-024-01143-6.

Proliferative Vitreoretinopathy in Retinal Detachment: Perspectives on Building a Digital Twin Model Using Nintedanib.

Visioli G, Romaniello A, Spinoglio L, Albanese G, Iannetti L, Gagliardi O Int J Mol Sci. 2024; 25(20).

PMID: 39456855 PMC: 11507981. DOI: 10.3390/ijms252011074.

In-silico screening of phytomolecules against multiple targets for wound management.

Thomas A, Shinde S, Wavhale R, Jadhav P, Tambe S, Lokhande K In Silico Pharmacol. 2024; 12(1):19.

PMID: 38550524 PMC: 10965871. DOI: 10.1007/s40203-024-00194-4.

Proliferative vitreoretinopathy: an update on the current and emerging treatment options.

Desideri L, Artemiev D, Zandi S, Zinkernagel M, Anguita R Graefes Arch Clin Exp Ophthalmol. 2023; 262(3):679-687.

PMID: 37843566 PMC: 10907475. DOI: 10.1007/s00417-023-06264-1.

A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study.

Charteris D, Cro S, Casswell E, Tudor Edwards R, Ezeofor V, Anthony B Health Technol Assess. 2023; 27(12):1-50.

PMID: 37840322 PMC: 10591211. DOI: 10.3310/GNBJ1387.

References

Mandelcorn M, MACHEMER R, Fineberg E, Hersch S . Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants. Am J Ophthalmol. 1975; 80(2):227-37. DOI: 10.1016/0002-9394(75)90137-3. View

MUELLER-JENSEN K, MACHEMER R, Azarnia R . Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber. Am J Ophthalmol. 1975; 80(3 Pt 2):530-7. DOI: 10.1016/0002-9394(75)90222-6. View

CLARKSON J, Green W, Massof D . A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol. 1977; 84(1):1-17. View

VAN HORN D, AABERG T, MACHEMER R, Fenzl R . Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1977; 84(3):383-93. DOI: 10.1016/0002-9394(77)90684-5. View

MACHEMER R, Van Horn D, AABERG T . Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978; 85(2):181-91. DOI: 10.1016/s0002-9394(14)75946-x. View

Brinkman C, Broekhuyse R . Cell-mediated immunity after retinal detachment as determined by lymphocyte stimulation. Am J Ophthalmol. 1978; 86(2):260-5. DOI: 10.1016/s0002-9394(14)76822-9. View

Rachal W, Burton T . Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol. 1979; 97(3):480-3. DOI: 10.1001/archopht.1979.01020010230008. View

Leaver P, Grey R, Garner A . Silicone oil injection in the treatment of massive preretinal retraction. II. Late complications in 93 eyes. Br J Ophthalmol. 1979; 63(5):361-7. PMC: 1043489. DOI: 10.1136/bjo.63.5.361. View

Tano Y, Sugita G, Abrams G, MACHEMER R . Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol. 1980; 89(1):131-6. DOI: 10.1016/0002-9394(80)90239-1. View

10.

Campochiaro P, Bryan 3rd J, Conway B, Jaccoma E . Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. Arch Ophthalmol. 1986; 104(11):1685-7. DOI: 10.1001/archopht.1986.01050230123046. View

11.

Harvey A, Roberge F, Hjelmeland L . Chemotaxis of rat retinal glia to growth factors found in repairing wounds. Invest Ophthalmol Vis Sci. 1987; 28(7):1092-9. View

12.

Wiedemann P, Lemmen K, Schmiedl R, Heimann K . Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol. 1987; 104(1):10-4. DOI: 10.1016/0002-9394(87)90286-8. View

13.

Doekes G, van der Gaag R, Rothova A, van Kooyk Y, Broersma L, Zaal M . Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res. 1987; 6(7):909-19. DOI: 10.3109/02713688709034859. View

14.

Wilkes S, Mansour A, Green W . Proliferative vitreoretinopathy. Histopathology of retroretinal membranes. Retina. 1987; 7(2):94-101. View

15.

Lambrou F, Burke J, AABERG T . Effect of silicone oil on experimental traction retinal detachment. Arch Ophthalmol. 1987; 105(9):1269-72. DOI: 10.1001/archopht.1987.01060090127042. View

16.

Chandler D, Hida T, Sheta S, Proia A, MACHEMER R . Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. Graefes Arch Clin Exp Ophthalmol. 1987; 225(4):259-65. DOI: 10.1007/BF02150144. View

17.

Czaja M, Weiner F, Giambrone M, Eghbali M, Zern M . Differential effects of gamma-interferon on collagen and fibronectin gene expression. J Biol Chem. 1987; 262(27):13348-51. View

18.

Postlethwaite A, Raghow R, Stricklin G, Poppleton H, Seyer J, Kang A . Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol. 1988; 106(2):311-8. PMC: 2114989. DOI: 10.1083/jcb.106.2.311. View

19.

Lewis H, AABERG T . Anterior proliferative vitreoretinopathy. Am J Ophthalmol. 1988; 105(3):277-84. DOI: 10.1016/0002-9394(88)90010-4. View

20.

Williams G, Lambrou F, Jaffe G, Snyder R, Green G, Devenyi R . Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Arch Ophthalmol. 1988; 106(8):1055-8. DOI: 10.1001/archopht.1988.01060140211025. View